News
TELA
0.8600
-8.69%
-0.0818
Analysts Are Bullish on These Healthcare Stocks: Achieve Life Sciences (QUIT), Atara Biotherapeutics (ATRA)
TipRanks · 1d ago
Analysts Offer Insights on Healthcare Companies: REPRO-MED Systems (KRMD), Legend Biotech (LEGN) and TELA Bio (TELA)
TipRanks · 1d ago
TELA Bio Q3 2026 Earnings Call Transcript
Benzinga · 2d ago
Tela Bio files $150M mixed securities shelf
TipRanks · 2d ago
TELA Bio, Inc. (TELA) Reports Q3 Loss, Beats Revenue Estimates
NASDAQ · 2d ago
Tela Bio reports Q3 EPS (16c), consensus (16c)
TipRanks · 2d ago
*TELA Bio 3Q Loss $9.3M >TELA
Dow Jones · 2d ago
*TELA Bio 3Q Loss/Shr 16c >TELA
Dow Jones · 2d ago
*TELA Bio 3Q Rev $19M >TELA
Dow Jones · 2d ago
Press Release: TELA Bio Reports Third Quarter 2026 Financial Results
Dow Jones · 2d ago
Weekly Report: what happened at TELA last week (1102-1106)?
Weekly Report · 4d ago
Weekly Report: what happened at TELA last week (1026-1030)?
Weekly Report · 11/02 09:17
Weekly Report: what happened at TELA last week (1019-1023)?
Weekly Report · 10/26 09:17
Weekly Report: what happened at TELA last week (1012-1016)?
Weekly Report · 10/19 09:17
Weekly Report: what happened at TELA last week (1005-1009)?
Weekly Report · 10/12 09:18
TELA Bio Shareholders Approve Future Reverse Split Flexibility
TipRanks · 10/08 20:32
TELA Bio Regains Nasdaq Compliance, Securing Listing Status
TipRanks · 10/06 20:37
TELA Bio Says FDA Grants 510(k) Clearance For Liora Monofilament Scaffold Product
NASDAQ · 10/05 12:26
Tela Bio gets FDA clearance for Liora Monofilament Scaffold
TipRanks · 10/05 12:16
Weekly Report: what happened at TELA last week (0928-1002)?
Weekly Report · 10/05 09:18
More
Webull provides a variety of real-time TELA stock news. You can receive the latest news about Tela Bio, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About TELA
TELA Bio, Inc. is a commercial-stage medical technology company. The Company is focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. Its first portfolio of products, the OviTex Reinforced Tissue Matrix (OviTex), addresses unmet needs in hernia repair and abdominal wall reconstruction. Its OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair. The Company's OviTex products include OviTex 1S, OviTex 2S, OviTex LPR, and OviTex IHR. Its second portfolio of products, the OviTex PRS Reinforced Tissue Matrix (OviTex PRS), addresses unmet needs in plastic and reconstructive surgery. OviTex PRS is indicated for use in implantation to reinforce soft tissue where weakness exists in patients requiring soft-tissue repair.